Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study
Study Details
Study Description
Brief Summary
The aim of the present study is to develop a protocol for optimal corneal 3-dimensional imaging based on measurements in healthy volunteers. For this purpose, a customized ultra-high resolution Spectral Domain OCT will be used. To validate whether the protocol can also be applied in patients with corneal pathologies, for whom it is intended to be used, measurements in these patients will be performed. We propose to obtain images from patients with keratoconus, since this is one of the most frequent causes for corneal transplantations in Europe and from patients with corneal neovascularization which is a major cause of vision loss in several ophthalmic diseases. Based on the obtained measurement protocol, further studies investigating the pathophysiology or treatment success of several corneal pathologies can be planned.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Healthy volunteers 10 healthy volunteers |
Device: Optical Coherence Tomography
Imaging of the cornea using ultrahigh resolution Spectral Domain OCT
|
Other: Corneal Neovascularisation 5 patients with corneal neovascularisation |
Device: Optical Coherence Tomography
Imaging of the cornea using ultrahigh resolution Spectral Domain OCT
|
Other: Keratoconus 5 patients with keratoconus |
Device: Optical Coherence Tomography
Imaging of the cornea using ultrahigh resolution Spectral Domain OCT
|
Outcome Measures
Primary Outcome Measures
- Corneal Imaging [1 day]
Development of a measurement protocol for 3 dimensional imaging of the human cornea
Secondary Outcome Measures
- Imaging of corneal pathologies [1 day]
Application of the protocol in patients with corneal pathologies
Eligibility Criteria
Criteria
Inclusion Criteria:
Healthy volunteers:
-
Men and women aged over 18 years
-
Normal findings in the slit lamp examination, no corneal pathologies
Patients with keratoconus:
-
Men and women aged over 18 years
-
Presence of keratoconus
-
No ophthalmic surgery in the 3 months preceding the study
Patients with corneal neovascularization:
-
Men and women aged over 18 years
-
Presence of corneal neovascularization
-
No ophthalmic surgery in the 3 months preceding the study
Exclusion Criteria:
-
Participation in a clinical trial in the previous 3 weeks
-
Presence of any abnormalities preventing reliable measurements as judged by the investigator
-
Pregnancy, planned pregnancy or lactating
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Clinical Pharmacology | Vienna | Austria | 1090 |
Sponsors and Collaborators
- Medical University of Vienna
Investigators
- Principal Investigator: Katarzyna Napora, MD, PhD, Department of Clinical Pharmacology, Medical University of Vienna
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- OPHT-040413